Table 3.
Inclusion Criteria: | Exclusion Criteria: |
---|---|
Out-patient clinic recruitment (Of 202 recruited patients who participated in a genotype-phenotype multiple sclerosis (MS) study 92 patients were included into this study by random.) | – |
Informed consent (in accordance with the approval requirements of the local ethics committee.) | – |
Clinical stability (magnetic resonace imaging (MRI) scan of patients with an acute relapse was postponed for at least 30 days after the last dose of steroid treatment.) | – |
– | Motion artefacts (This concerned 3/92 patients.) |
Lesional volume alterations (This concerned 69/92 patients.) | Volumetric stability over the 12 month observation period (This concerned 20/92 patients.) |